Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
Provided By GlobeNewswire
Last update: Oct 21, 2024
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that it will participate in the following upcoming healthcare investment conferences:
Read more at globenewswire.com
